Clinical Trial Update: Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating buparlisib (BKM120) in advanced head and neck squamous cell carcinoma is listed. The current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• BKM120 (Buparlisib)

Snippet

Sponsor: Yonsei University | Conditions: Head Neck Cancer Squamous Cell Metastatic, Head Neck Cancer Squamous Cell Recurrent | Phase 2 | Status: UNKNOWN